Baymatob: Australian startups receive $18.5 M to commercialise research to cure blindness, find cancer, and make childbirth safer

The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their research and help turn their discoveries into new medicines and treatment tools for cancer, pregnancy complications, eye damage, and other conditions. Mirugen has received almost $2 million to develop a gene therapy which could potentially cure some types of blindness by regenerating cells in the eye to help restore vision. OncoRes Medical will receive $2.5 million to create a device to help surgeons to better identify cancer cells during surgery. By ensuring all cancerous cells are removed, the device could improve the success rate for initial surgery and reduce the need for follow-up surgery.